{
  "url": "https://www.law.cornell.edu/regulations/new-york/14-NYCRR-710.4",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 14 ยง 710.4 - Applications to the Surrogate Decision-Making Committee",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 14 ยง 710.4 - Applications to the Surrogate Decision-Making Committee\n\nState Regulations\n(a) Applications to the surrogate\ndecision-making committee must include a declaration setting forth the\ndeclarant's reasons for the beliefs that: 1)\nthe patient lacks the capacity to consent to a proposed treatment, 2)\nthere is no available and willing\nsurrogate to make the decision, and\n3)\nthe proposed treatment serves the\npatient's best interests; and supporting documents, if necessary, as set forth\nin this Part. (b) Declaration in support of surrogate decision-making\n(1)\nA declarant may file the declaration on\nbehalf of any qualifying patient, as defined in article 80 of the MHL and\narticle 17-A of the SCPA. (2)\n\nFor\ndeclarations regarding major medical treatment decisions pursuant to article 80\nof the MHL, the declaration must be made in writing and include, inter alia, the following: (i) a brief description of the\nproposed major medical treatment; (ii)\na statement that the patient does not\nhave a parent, spouse, adult child, legal guardian or other surrogate who is\nlegally authorized, available and willing to make the major medical treatment\ndecision; the factual basis for such a statement; and the efforts made to\ncontact such persons; (ii)\na\ndescription of the patient's opinion or reaction, if any, when the proposed\nmajor medical treatment decision was explained; (iii)\nthe reasons for believing that the\npatient lacks the capacity to make the major medical treatment decision; and\n(iv)\na statement of the\ndeclarant's opinion of whether the best interests of the patient would be\npromoted by such treatment decision and the basis for the\nopinion. (3)\n\nFor\ndeclarations regarding decisions to withhold or withdraw life-sustaining\ntreatment, pursuant to article 17-A of the SCPA, the declaration must be made\nin writing and include, inter alia, the following: (i) a statement that the patient does not\nhave a parent, spouse, adult child, legal guardian or other surrogate who is\nlegally authorized, available and willing to make the decision to withhold or\nwithdraw life-sustaining treatment; the factual basis for such a statement; and\nthe efforts made to contact such persons; (ii)\na description of the proposed\nlife-sustaining treatment to be withheld or withdrawn; (iii)\na description of the efforts to\ndetermine the moral and religious beliefs of the patient, and such beliefs, if\nknown; (iv)\na description of the\npatient's opinion or reaction, if any, when the proposed withholding or\nwithdrawing of life-sustaining treatment was explained; (v) the reasons for believing that the\npatient lacks capacity to provide informed consent; and\n(vi)\na statement of the declarant's opinion\nwhether the best interests of the patient would be promoted by such decision\nand the basis for that opinion. (4)\n\nThe declaration shall be signed and dated\nby the declarant, stating that the information on the declaration is true to\nthe best of the declarant's knowledge. (5)\nA declaration regarding a minor patient\nmust indicate whether the patient's parents are deceased, or have had their\nparental rights terminated, or have waived their right to make the\ndecision. (c) Supporting\ndocuments\n(1)\n\nFor applications regarding major\nmedical treatment decisions, the following documents must be submitted along\nwith the declaration: (i) A statement\ncompleted, signed and dated by a psychiatrist or psychologist duly licensed by\nthe State of New York, providing the factual basis and professional opinion\nthat the patient lacks the capacity to make the major medical treatment\ndecision. (ii)\nA statement\ncompleted, signed and dated by a physician, podiatrist, or dentist including: (A)\na description of the proposed major\nmedical treatment decision and the patient's medical, podiatric, or dental\ncondition which requires such treatment decision indicating the date of\ndiagnosis; (B)\nthe risks and\nbenefits to the patient of the proposed treatment decision and any alternative\ntreatments including consideration of non-treatment; (C)\na statement whether the patient has any\nmedical, podiatric, or dental condition which would prevent their presence at\nthe panel hearing and a description of such condition; and\n(D)\na statement whether there is a need for\nan expedited review including the factual and medical justification for such a\nreview. (iii)\nA statement\ncompleted, signed and dated by someone responsible for the patient's medical\nchart providing supplemental medical information including: (A)\na description of the current medications\nof the patient, any known allergies, the dates of the last physical\nexamination, EKG, chest X-ray, and laboratory workup; (B)\na history of any cardiac or pulmonary\ndisease and any other major illness or surgery within the previous year; and\n(C)\na statement of any known\nprimary or secondary physical conditions. (iv)\n\nAny other information that may be\nnecessary to determine the need for such treatment decision, including a copy\nof a of any pertinent evaluation or data regarding the\npatient. (2)\n\nFor\napplications regarding decisions to withhold or withdraw life-sustaining\ntreatment, the following documents must be submitted with the declaration: (i) A certification on capacity, as required\nby section 1750-b of the SCPA, including: (A)\nA statement completed, signed and dated by the attending physician, certifying\nthat to a reasonable degree of medical certainty the patient lacks capacity to\nmake health care decisions, and stating the attending physician's opinion as to\nthe cause and nature of the incapacity and its extent and probable\nduration; (B)\nA statement\ncompleted, signed and dated by a consulting physician or psychologist, providing the factual basis and professional opinion that such patient lacks\nthe capacity to make the end-of-life decision; (C)\nA statement that either the attending\nphysician or consulting physician or psychologist: (I)\nis employed by a developmental\ndisabilities services office named in section 13.17 of the MHL or employed by\nOPWDD to provide treatment and care to people with developmental\ndisabilities; (II)\nhas been\nemployed for a minimum of two years to render care and service in a facility or\nprogram operated, certified or authorized by OPWDD; (III)\nhas been approved by the commissioner\nof OPWDD; or\n(IV)\notherwise\nsatisfies the statutory requirements of section\n1750-b. (ii)\nA\ncertification on the appropriateness of withdrawal or withholding of\nlife-sustaining treatment, completed, signed and dated by the attending\nphysician and including: (A)\n\nThe risks and\nbenefits of withholding or withdrawing life-sustaining treatment, taking into\nconsideration the extraordinary burdens to the patient of providing\nlife-sustaining treatment in light of the patient's: (I)\nmedical condition, other than such\npatient's developmental disability; and\n(II)\nthe expected outcome of providing\nlife-sustaining treatment, notwithstanding the patient's developmental\ndisability, and whether there are any alternative treatments available to the\npatient; and\n(III)\nin the case of a\ndecision to withdraw or withhold artificially provided nutrition or hydration, a certification that there is no reasonable hope of maintaining life, or a\ncertification that the artificially provided nutrition or hydration poses an\nextraordinary burden. (B)\nA statement that to a reasonable degree of medical certainty the patient has a\nmedical condition that is: (I)\na terminal\ncondition in that the patient has an illness or injury from which there is no\nrecovery and which reasonably can be expected to cause death within one\nyear; (II)\npermanent\nunconsciousness; or\n(III)\na medical\ncondition other than the patient's developmental disability, which requires\nlife-sustaining treatment, is irreversible and which will continue\nindefinitely. (C)\nA\nstatement whether there is a need for an expedited review including the factual\nand medical justification for such a review; and\n(iii)\nA statement completed, signed and dated\nby someone responsible for the patient's medical chart, providing supplemental\nmedical information including: (A)\na\ndescription of the current medications of the patient, any known allergies, the\ndates of the last physical examination, EKG, chest X-ray, and laboratory\nworkup; and\n(B)\na history of any\ncardiac or pulmonary disease and any other major illness or surgery within the\nprevious year; and\n(C)\na statement\nof any known primary or secondary physical conditions. (iv)\nA certification on the appropriateness\nof withdrawal or withholding of life-sustaining treatment, completed, signed\nand dated by the consulting physician or psychologist, and including all the\nrequired information as defined above for the attending physician's\ncertification on the appropriateness of withdrawal or withholding of\nlife-sustaining treatment. (3)\n\nIn the event that confidential\ninformation regarding acquired immune deficiency syndrome (AIDS), an infection\nwith HIV, or related virus or illness is relevant to the panel's review, such\ninformation will be submitted to the committee as a supplemental statement or\nstatements as authorized by PHL section 2782(1)(a). (d) The declaration and supporting documents\nmust be filed with the surrogate decision-making committee program staff to\ninitiate the review of the request on behalf of a patient. Notes\nN.Y. Comp. Codes R. & Regs. Tit. 14\nยง\n710.4\n\nRenumbered\nfrom 710.3\n\nNew\n\nYork State Register September 26, 2018/Volume XL, Issue 39, eff. 11/28/2018\n\nAmended\n\nNew\n\nYork State Register February 12, 2025/Volume XLVII, Issue 06, eff. 2/12/2025\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 13370
}